Zobrazeno 1 - 8
of 8
pro vyhledávání: '"N Avola"'
Publikováno v:
European Journal of Hospital Pharmacy. 21:A73.1-A73
Background Anti-EGFR chemotherapy drugs cause skin toxicity due to high numbers of receptors in keratinocytes of the epidermis, sebaceous glands, epithelial hair follicles. Cetuximab treatment for metastatic colorectal cancer causes rash (1st to 4th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::01c79651bf0993110bfb4044f5a0ab0c
https://doi.org/10.1136/ejhpharm-2013-000436.180
https://doi.org/10.1136/ejhpharm-2013-000436.180
Publikováno v:
European Journal of Hospital Pharmacy. 21:A72.3-A73
Background In Azienda Sanitaria Provinciale (ASP) Siracusa Gardasil is the vaccine administered against HPV. Gardasil, a quadrivalent vaccine, contains antigens from double-stranded DNA virus. It has limited post-marketing experience, so its safety i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c1d197f7350c42972f32b212d5e28962
https://doi.org/10.1136/ejhpharm-2013-000436.179
https://doi.org/10.1136/ejhpharm-2013-000436.179
Publikováno v:
European Journal of Hospital Pharmacy. 21:A93.1-A93
Background Psoriasis is a chronic disease that significantly affects patients’ quality of life (QoL). Biological drugs interfere in the immunological processes that trigger and support psoriasis and, therefore, prove effective in its treatment. Pur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::162359c34e9207a9c92432203bed9756
https://doi.org/10.1136/ejhpharm-2013-000436.228
https://doi.org/10.1136/ejhpharm-2013-000436.228
Publikováno v:
European Journal of Hospital Pharmacy. 21:A73.2-A74
Background In Syracuse PHA from 01/11/2007 the drug olanzapine (Zyprexa) was dispensed by the National Health System, in accordance with AIFA guidelines. In October 2011 the generic drug was introduced in the AIFA transparency lists and since Februar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::48842fcaf6f1b9301f25d3a353d4cca0
https://doi.org/10.1136/ejhpharm-2013-000436.181
https://doi.org/10.1136/ejhpharm-2013-000436.181
Autor:
E Migliorisi, S Regolo, R Sorbello, G Cacciaguerra, N Avola, S Guzzardi, D Sgarlata, F Ferlito, D Spadaro
Publikováno v:
European Journal of Hospital Pharmacy. 20:A214.2-A214
Background Rheumatic diseases are chronic diseases with a high cost. New drugs are the anti-TNF inhibitors adalimumab (A) and etanercept (E). The Infectious Diseases Unit of Umberto I Hospital, Syracuse, Italy, was identified as a Regional Centre for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3d566edacb6be267a257b7135e41291d
https://doi.org/10.1136/ejhpharm-2013-000276.593
https://doi.org/10.1136/ejhpharm-2013-000276.593
Publikováno v:
European Journal of Hospital Pharmacy. 20:A146.2-A146
Background The increased prevalence of chronic diseases, including diabetes, requires a critical review of models of care and the introduction of new strategies of intervention. Health Literacy (HL) is a tool for educating patients in order to increa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b55aef0b8fa07f7852277aee40d1dba7
https://doi.org/10.1136/ejhpharm-2013-000276.404
https://doi.org/10.1136/ejhpharm-2013-000276.404
Publikováno v:
European Journal of Hospital Pharmacy. 20:A161.2-A161
Background In Italy respiratory diseases are the third cause of death, 50% of which is caused by Chronic Obstructive Pulmonary Disease (COPD). COPD is an irreversible inflammation that causes narrowing of the airways and has a slow and progressive co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad2d451f856d8b1812e1f67ce5a4fa73
https://doi.org/10.1136/ejhpharm-2013-000276.447
https://doi.org/10.1136/ejhpharm-2013-000276.447
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.